Remote login software and other innovations to enhance scale-up of point-of-care HPV testing in high-burden, low-income settings

Abstract

Molecular diagnosis of HPV at the point of care (POC) is an important technological development because the highest rates of HPV infection are often found in low-resource settings (LRS) or very remote locations in high-resource settings (HRS). The burden of HPV-related morbidity and mortality in LRS is high and requires immediate action in order to be contained or eliminated. However, accurate estimates of prevalence and risk factors are not available in many countries, and current HPV testing capacity varies considerably.